Cue Biopharma IncNASDAQ:CUE
- LAST PRICE3.3100
- TODAY'S CHANGE (%)-0.0700 (-2.0710%)
- Bid / Lots3.2900/ 20
- Ask / Lots3.5900/ 1
- Open / Previous Close3.3800 / 3.3800
- Day Range
- 52 Week Range
- Volume161,683
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CUE |
|---|---|---|
| 09:32 ET | 4448 | 3.4 |
| 09:34 ET | 100 | 3.4 |
| 09:36 ET | 700 | 3.39 |
| 09:38 ET | 5950 | 3.39 |
| 09:39 ET | 100 | 3.39 |
| 09:41 ET | 100 | 3.35 |
| 09:50 ET | 3122 | 3.39 |
| 09:52 ET | 300 | 3.4 |
| 09:54 ET | 15116 | 3.45 |
| 09:56 ET | 15485 | 3.45 |
| 09:57 ET | 400 | 3.4 |
| 10:03 ET | 1500 | 3.38 |
| 10:06 ET | 1106 | 3.38 |
| 10:12 ET | 600 | 3.34 |
| 10:14 ET | 3400 | 3.315 |
| 10:15 ET | 3000 | 3.3398 |
| 10:17 ET | 3143 | 3.34 |
| 10:24 ET | 100 | 3.38 |
| 10:26 ET | 100 | 3.35 |
| 10:30 ET | 100 | 3.35 |
| 10:33 ET | 100 | 3.33 |
| 10:39 ET | 100 | 3.355 |
| 10:42 ET | 100 | 3.37 |
| 10:53 ET | 1546 | 3.33 |
| 10:57 ET | 100 | 3.36 |
| 11:06 ET | 100 | 3.365 |
| 11:09 ET | 200 | 3.355 |
| 11:22 ET | 100 | 3.35 |
| 11:24 ET | 4690 | 3.39 |
| 11:27 ET | 215 | 3.3721 |
| 11:31 ET | 100 | 3.39 |
| 11:33 ET | 980 | 3.39 |
| 11:36 ET | 500 | 3.39 |
| 11:38 ET | 2858 | 3.42 |
| 11:42 ET | 100 | 3.44 |
| 11:54 ET | 100 | 3.46 |
| 11:58 ET | 950 | 3.48 |
| 12:00 ET | 300 | 3.47 |
| 12:05 ET | 100 | 3.48 |
| 12:14 ET | 100 | 3.48 |
| 12:16 ET | 100 | 3.43 |
| 12:27 ET | 100 | 3.48 |
| 12:34 ET | 844 | 3.4437 |
| 12:36 ET | 200 | 3.46 |
| 12:45 ET | 100 | 3.48 |
| 12:52 ET | 1510 | 3.48 |
| 12:59 ET | 150 | 3.4503 |
| 01:06 ET | 1400 | 3.4799 |
| 01:08 ET | 2299 | 3.48 |
| 01:10 ET | 747 | 3.48 |
| 01:12 ET | 5606 | 3.49 |
| 01:14 ET | 300 | 3.49 |
| 01:15 ET | 716 | 3.5 |
| 01:17 ET | 1600 | 3.5 |
| 01:19 ET | 5147 | 3.52 |
| 01:21 ET | 2050 | 3.5199 |
| 01:26 ET | 100 | 3.52 |
| 01:28 ET | 1621 | 3.51 |
| 01:35 ET | 2300 | 3.48 |
| 01:37 ET | 600 | 3.48 |
| 01:46 ET | 216 | 3.465 |
| 01:50 ET | 100 | 3.47 |
| 01:51 ET | 1435 | 3.43 |
| 01:55 ET | 100 | 3.42 |
| 01:57 ET | 800 | 3.396 |
| 02:00 ET | 3284 | 3.32 |
| 02:04 ET | 100 | 3.325 |
| 02:08 ET | 1230 | 3.325 |
| 02:11 ET | 2000 | 3.3031 |
| 02:13 ET | 100 | 3.33 |
| 02:20 ET | 700 | 3.305 |
| 02:22 ET | 1920 | 3.31 |
| 02:24 ET | 100 | 3.3199 |
| 02:27 ET | 200 | 3.31 |
| 02:31 ET | 2655 | 3.32 |
| 02:33 ET | 1003 | 3.31 |
| 02:38 ET | 800 | 3.3 |
| 02:40 ET | 300 | 3.31 |
| 02:42 ET | 1583 | 3.33 |
| 02:44 ET | 1545 | 3.34 |
| 02:47 ET | 1157 | 3.35 |
| 02:49 ET | 399 | 3.36 |
| 02:51 ET | 300 | 3.35 |
| 03:00 ET | 800 | 3.33 |
| 03:02 ET | 100 | 3.33 |
| 03:12 ET | 200 | 3.325 |
| 03:21 ET | 100 | 3.325 |
| 03:23 ET | 500 | 3.35 |
| 03:27 ET | 662 | 3.35 |
| 03:30 ET | 1000 | 3.3176 |
| 03:36 ET | 2906 | 3.3234 |
| 03:38 ET | 2787 | 3.35 |
| 03:39 ET | 100 | 3.35 |
| 03:43 ET | 469 | 3.35 |
| 03:45 ET | 100 | 3.35 |
| 03:50 ET | 452 | 3.335 |
| 03:52 ET | 400 | 3.32 |
| 03:54 ET | 300 | 3.31 |
| 03:56 ET | 200 | 3.33 |
| 03:57 ET | 950 | 3.35 |
| 03:59 ET | 600 | 3.31 |
Today
Yesterday
BRIEF-Cue Biopharma Reports Fourth Quarter Results , from 4:12PM ET on Tuesday Mar 21, 2023 by Thomson Reuters
4:12PM ET on Tuesday Mar 21, 2023 by Thomson ReutersCue Biopharma Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights, from 4:10PM ET on Tuesday Mar 21, 2023 by GlobeNewswire
4:10PM ET on Tuesday Mar 21, 2023 by GlobeNewswire
Mar 15, 2023
Cue Biopharma to Host Business Update Call and Webcast, from 8:00AM ET on Wednesday Mar 15, 2023 by GlobeNewswire
8:00AM ET on Wednesday Mar 15, 2023 by GlobeNewswire
Mar 1, 2023
Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences, from 8:00AM ET on Wednesday Mar 01, 2023 by GlobeNewswire
8:00AM ET on Wednesday Mar 01, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cue Biopharma Inc | 145.5M | -2.4x | --- |
Ikena Oncology Inc | 152.3M | -2.0x | --- |
Aravive Inc | 147.2M | -1.0x | --- |
Milestone Pharmaceuticals Inc | 118.3M | -2.2x | --- |
DURECT Corp | 113.6M | -3.0x | --- |
Absci Corp | 161.7M | -1.4x | --- |
Company Information
Cue Biopharma Inc is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes MHC Class I Program, and MHC Class II Program. The CUE-100 Framework restricts the activity of T cell populations. The CUE-200 Framework enables potent, long-lived anti-tumor T cell responses. The Autoimmune disease therapy protects the healthy cells from immune attack.
Contact Information
- Headquarters
- 40 Guest StreetBOSTON, MA, United States 02135
- Phone
- 617-949-2680
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Frank Morich
- President, Chief Scientific Officer
- Anish Suri
- Chief Executive Officer, Director
- Daniel Passeri
- Chief Financial Officer
- Kerri-Ann Millar
- Senior Vice President, General Counsel, Secretary
- Colin Sandercock
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $145.5M |
|---|---|
Revenue (TTM) | $9.3M |
Shares Outstanding | 43.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.98 |
EPS | $-1.38 |
Book Value | $2.03 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 15.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -494.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
